[1] Walther C, Guenet J L, Simon D, et al. Pax: a murine multigene family of paired box-containing genes[J]. Genomics, 1991,11(2):424.
[2] Mansouri A, Hallonet M, Gruss P. Pax genes and their roles in cell differentiation and development[J]. Curr Opin Cell Biol, 1996,8(6):851-857.
[3] Underhill D A. PAX proteins and fables of their reconstruction[J]. Crit Rev Eukaryot Gene Expr, 2012,22(2):161-177.
[4] Wang Q, Fang W H, Krupinski J, et al. Pax genes in embryogenesis and oncogenesis[J]. J Cell Mol Med, 2008,12(6A):2281-2294.
[5] Chi N, Epstein J A. Getting your Pax straight: Pax proteins in development and disease[J]. Trends Genet, 2002,18(1):41-47.
[6] Blake J A, Thomas M, Thompson J A, et al. Perplexing Pax: from puzzle to paradigm[J]. Dev Dyn, 2010,237(10):2791-2803.
[7] Paixo-Crtes V R, Salzano F M, Bortolini M C. Evolutionary history of chordate PAX genes: dynamics of change in a complex gene family[J]. PLoS One, 2013,8(9):e73560.
[8] Robson E J, Shu-Jie H, Eccles M R. A PANorama of PAX genes in cancer and development[J]. Nat Rev Cancer, 2006,6(1):52-62.
[9] Mahajan P, Leavey P J, Galindo R L. PAX genes in childhood oncogenesis: developmental biology gone awry?[J]. Oncogene, 2015,34(21):2681-2689.
[10] Chen X, Huang H, Wang H, et al. Characterization of zebrafish Pax1b and Pax9 in fin bud development[J]. Biomed Res Int, 2014,2014(1):309385.
[11] Liu X, Li G, Liu X, et al. The role of the Pax1/9 gene in the early development of amphioxus pharyngeal gill slits[J]. J Exp Zool B Mol Dev Evol, 2015,324(1):30-40.
[12] Su D M, Manley N R. Stage-specific changes in fetal thymocyte proliferation during the CD4^-8^- to CD4⁺8⁺ transition in wild type, Rag1 -/- , and Hoxa3,Pax1 mutant mice[J]. BMC, 2002,3(1):12.
[13] Hung-Cheng L, Ya-Wen L, Huang T H , et al. Identification of novel DNA methylation markers in cervical cancer[J]. Int J Cancer, 2008,123(1):161-167.
[14] Lim E H, Shi L N, Jia L L, et al. Cervical dysplasia: assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy[J]. Gynecol Oncol, 2010,119(2):225-231.
[15] Jun X, Ling X, Baohua Y, et al. Assessing methylation status of PAX1 in cervical scrapings, as a novel diagnostic and predictive biomarker, was closely related to screen cervical cancer[J]. Int J Clin Exp Pathol, 2015,8(2):1674-1681.
[16] Ling-Ying K, Wei D, Li W, et al. PAX1 methylation hallmarks promising accuracy for cervical cancer screening in asians: results from a meta-analysis[J]. Clin Lab, 2015,61(10):1471.
[17] Yi Z, Chen F Q, Sun Y H, et al. Effects of DNMT1 silencing on malignant phenotype and methylated gene expression in cervical cancer cells[J]. J Exp Clin Cancer Res, 2011,30(1):98.
[18] Joosten P H, Hol F A, Beersum S E V, et al. Altered regulation of platelet-derived growth factor receptor-alpha gene-transcription in vitro by spina bifida-associated mutant Pax1 proteins[J]. Proc Natl Acad Sci U S A, 1998,95(24):14459-14463.
[19] Parashar G, Capalash N. Promoter methylation-independent reactivation of PAX1 by curcumin and resveratrol is mediated by UHRF1[J]. Clin Exp Med, 2016,16(3):471-478.
[20] Zhen-Ming W. PAX1 methylation analysis by MS-HRM is useful in triage of high-grade squamous intraepithelial lesions[J]. Asian Pac J Cancer Prev, 2014,15(2):891-894.
[21] Yung-Kai H, Bou-Yu P, Chia-Yo W, et al. DNA methylation of PAX1 as a biomarker for oral squamous cell carcinoma[J]. Clin Oral Investig, 2014,18(3):801.
[22] Phillips C D, Boyd B, Fondon J W, et al. Contrasting evolutionary dynamics of the developmental regulator PAX9, among bats, with evidence for a novel post-transcriptional regulatory mechanism[J]. PLoS One, 2013,8(2):e57649.
[23] Al F J J J. Generation and characterization of tamoxifen -inducible Pax9 -CreER knock -in mice using CrispR/Cas9[J]. Genesis, 2016,54(9):490-496.
[24] Jaskoll T, Zhou Y M, Chai Y, et al. Embryonic submandibular gland morphogenesis: stage-specific protein localization of FGFs, BMPs, Pax6 and Pax9 in normal mice and abnormal SMG phenotypes in FgfR2-IIIc(+/Delta), BMP7(-/-) and Pax6(-/-) mice[J]. Cells Tissues Organs, 2002,170(2-3):83-98.
[25] Almeida C V, Andrade S C, Saito C P, et al. Transcriptional analysis of the human PAX9 promoter[J].J Appl Oral Sci, 2010,18(5):482-492.
[26] Lee J C, Sharma M, Lee Y H, et al. Pax9 mediated cell survival in oral squamous carcinoma cell enhanced by c-myb[J]. Cell Biochem Funct, 2010,26(8):892-899.
[27] Josef-Karl G, Thomas R, Elisabeth K, et al. Progressive loss of PAX9 expression correlates with increasing malignancy of dysplastic and cancerous epithelium of the human oesophagus[J]. J Pathol, 2002,197(3):293-297.
[28] 谭炳煦. PAX9对食管鳞状细胞癌临床预后及放射敏感性的价值研究[D].济南:山东大学, 2016.
[29] Jude K, Qing L, Amy B, et al. Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer[J]. Proc Natl Acad Sci U S A, 2007,104(42):16663-16668.
[30] 安改丽, 喻 凤, 刘 莹, 等. miR-31调控PAX9对肺癌细胞增殖和侵袭能力的影响[J]. 解放军医药杂志, 2017,29(9):22-25.
[31] Hsu D S, Acharya C R, Balakumaran B S, et al. Characterizing the developmental pathways TTF-1, NKX2-8, and PAX9 in lung cancer[J]. Proc Natl Acad Sci U S A, 2009,106(13):5312-5317.
[32] 龚 蕊, 莫晓能, 邵 娟, 等. PAX9在非小细胞肺癌中的表达及其临床意义[J]. 江西医药, 2017,52(3):210-213.
[33] 陕 光, 钱辉军, 夏 樾. TBX2和PAX9在膀胱尿路上皮癌中高表达[J]. 中国组织化学与细胞化学杂志, 2015,24(5):409-412.
[34] 徐 傲, 陈 柯, 郭真理, 等. 子宫内膜样腺癌中TBX2、PAX9的表达及其相关性[J]. 临床与实验病理学杂志, 2012,28(2):158-161.
[35] 朱珊珊, 贾丽娜, 张鑫鑫, 等. PAX9在食管鳞癌细胞中的表达[J]. 锦州医科大学学报, 2016,37(6):5-8.